Figure 5. Blocking CREB phosphorylation at Ser142/143 blocks both components of ODP. A, left, An implanted mouse with two recording electrodes and two reference electrodes. The red cross on the mouse’s eye represents the MD, and VEPs are recorded from the hemisphere contralateral to the MD (contra eye deprived; red recording electrode) during stimulation of each eye individually. Right, Representative VEP traces before and after MD, with red lines indicating peak to trough amplitude of the VEP from the deprived eye (sutured closed during MD period) and open eye (remained open during MD period). Comparing responses before and after MD, Dc-ODP represents a decrease in VEP amplitude from stimulation of the deprived-eye stimulation, and Pc-ODP represents an increase in VEP amplitude from open-eye stimulation. A, left, Histogram showing that mice injected with HSV-GFP show the expected downward shift in OD after MD (p = 0.0004), whereas mice injected with CREBdn-S133A do not (n.s. = not significant, p = 0.07). Right, Mice injected with CREBdn-S142A/S143A also do not exhibit any OD shift (p = 0.40). C, left, Histogram showing Dc-ODP and Pc-ODP as expected in control mice (p = 0.04 and p = 0.01, respectively). Right, Both Dc-ODP and Pc-ODP are blocked in mice injected with CREBdn-S142A/S143A (p = 0.45 and p = 0.28, respectively). The data in the gray boxes were previously published in J Neurosci (Pulimood et al., 2017). Sample sizes (n) are specified in the histogram for each group. Data in B, C were statistically analyzed using paired t tests. All error bars indicate standard error of the mean (SEM). Contra = contralateral; Ipsi = ipsilateral; MD = monocular deprivation; Dc-ODP = depression component of ocular dominance plasticity; Pc-ODP = potentiation component of ocular dominance plasticity.